Accelerate your Oncology and protein biomarker discovery research with Olink's Proximity Extension Assay (PEA) technology
We’re excited to invite you to our in-person seminar on 16 February from 10:30 am – 11:45 am in Oslo. In this session, you will learn how protein biomarkers are used in early cancer detection research and how the new Olink service at the Proteomics Core Facility at Oslo University Hospital can help you reach your protein biomarker research goals – offering a range of disease-and biology-focused PEA panels as well as flexible options enabling you to design your own custom panel.
Kicking off our session is Tuula Nyman, Head of Proteomics at Oslo University Hospital, who will provide an introduction to the Proteomics Core Facility and the National network of Advanced Proteomics Infrastructure (NAPI), including the services they offer.
Then we hear from Renée Turzanski Fortner, Cancer epidemiologist at the Cancer Registry of Norway, who will share the details of a study using PEA for the detection of early cancer biomarkers in prospective cancer biobank samples.
And finally, our technical expert Olga Surova will provide an overview of the PEA technology and its applications, presenting case studies showing the value of protein biomarkers in accelerating Oncology research.
Register now to secure your seat and join us in Oslo. We look forward to seeing you at the seminar for a morning of proteomics!
Head of The Proteomic Core Facility, Oslo University Hospital
Renée Turzanski Fortner
Senior Researcher at the Cancer Registry of Norway and Group Leader in the Division of Cancer Epidemiology at the German Cancer Research Center